Mandate

Vinge advises Vostok New Ventures Ltd in connection with an investment in the ride-sharing service BlaBlaCar

August 11, 2016

Vinge has advised Vostok New Ventures Ltd (”Vostok”) in connection with an investment in the Paris based ride-sharing service Comuto SA (”BlaBlaCar”). Through the investment, Vostok has acquired shares in BlaBlaCar for a value of approximately EUR 40 million. The acquisition was made by an issue in kind where the purchase price for the shares in BlaBlaCar consisted of 6,866,766 newly issued shares in Vostok. The acquisition was approved by the Special General Meeting in Vostok on 5 August 2016 and new Swedish depository receipts for the issued shares are expected to be admitted for trading on Nasdaq Stockholm on 11 August 2016. Following the acquisition, Vostok owns approximately 5.4 % of the shares in BlaBlaCar.

Vostok New Ventures Ltd is an investment company with a special focus on online marketplaces and businesses with strong network effects. As of 31 March 2016, the net asset value of the group was USD 507.59 million. The Swedish depository receipts of Vostok New Ventures are listed on Nasdaq Stockholm, Mid Cap segment.

Vinge’s team primarily consisted of Jesper Schönbeck, Johan Göthberg, David Andersson, Amanda Knutsson, Nils Fredrik Dehlin and Ludvig Berke.

 

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025